What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
出版年份 2017 全文链接
标题
What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 142, Issue 4, Pages 709-718
出版商
Wiley
发表日期
2017-10-11
DOI
10.1002/ijc.31094
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study
- (2016) Rebecca Landy et al. BRITISH JOURNAL OF CANCER
- Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
- (2016) Kate T. Simms et al. INTERNATIONAL JOURNAL OF CANCER
- Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
- (2016) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
- (2016) Steffie K. Naber et al. PLoS One
- Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
- (2016) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Cancer Models and Real-world Data: Better Together: Table 1.
- (2015) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Cancer Models and Real-world Data: Better Together: Table 1.
- (2015) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
- (2014) HC Kitchener et al. HEALTH TECHNOLOGY ASSESSMENT
- Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?
- (2014) Margaretha A. Vink et al. INTERNATIONAL JOURNAL OF CANCER
- Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting
- (2014) Philip E. Castle et al. OBSTETRICS AND GYNECOLOGY
- Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
- (2014) Paulo S Naud et al. Human Vaccines & Immunotherapeutics
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
- (2012) Debbie Saslow et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
- (2012) Beatriz Serrano et al. Infectious Agents and Cancer
- Explaining variation in the uptake of HPV vaccination in England
- (2011) Varun M Kumar et al. BMC PUBLIC HEALTH
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- How many cervical cancers are prevented by treatment of screen-detected disease in young women?
- (2008) Peter Sasieni et al. INTERNATIONAL JOURNAL OF CANCER
- Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
- (2008) Margaret RE McCredie et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search